Research pen
ACTH-derived synthetic heptapeptide analogue
Semax is a synthetic peptide derivative of adrenocorticotropic hormone (ACTH). It is commonly utilised in laboratory research involving peptide structure, signalling pathways, and experimental biological systems.
For laboratory and research use only. Pen illustration is a visual reference. Confirm the supplied format and batch details with our team.
Semax Pen, 5 mg selected.
A complete reference
Semax is a synthetic peptide derivative of adrenocorticotropic hormone (ACTH). It is commonly utilised in laboratory research involving peptide structure, signalling pathways, and experimental biological systems.
Semax is a peptide analogue derived from specific ACTH fragments. In controlled research environments, it is used as a model compound in studies involving peptide interactions, receptor-associated pathways, and experimental biological frameworks.
Chemical reference information: CAS number: 80714-61-0; Molecular formula: C₃₇H₅₁N₉O₁₀S; Molecular weight: 813.92 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Semax 5 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.
Prepare a documentation requestContinue exploring
10 mg / 50 mg
5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule compound identified in scientific literature as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic pathways. NORVEXA research pen format.
Reference details
10 mg
ARA-290 (Cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin (EPO). NORVEXA research pen format.
Reference details
5 mg
AOD-9604 (Growth Hormone Fragment 177–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. NORVEXA research pen format.
Reference details